PROSTATE BIOPSY-RELATED SEPSIS: EPIDEMIOLOGY, RISK STRATIFICATION, AND PREVENTION STRATEGIES
DOI:
https://doi.org/10.31435/ijitss.3(51).2026.6628Keywords:
Prostate Biopsy, Sepsis, Urosepsis, Transrectal Biopsy, Transperineal Biopsy, Infectious Complications, Antibiotic Prophylaxis, Antimicrobial Resistance, Fluoroquinolone Resistance, Prostate CancerAbstract
Prostate biopsy remains an essential diagnostic procedure for confirming prostate cancer; however, biopsy-related infectious complications can result in emergency department visits, hospitalization, sepsis, and, rarely, septic shock. The infectious risk is particularly relevant to the transrectal approach, in which the biopsy needle traverses the rectal mucosa and can introduce enteric organisms into prostatic tissue and the bloodstream. The transition from transrectal to transperineal biopsy is the most important contemporary procedural development in infection prevention. Transperineal biopsy avoids direct traversal of the rectal mucosa and is associated with a lower infectious burden. Randomized evidence also indicates that transperineal biopsy can be performed under local anesthesia, and selected patients may undergo the procedure without antibiotic prophylaxis. When transrectal biopsy remains necessary, prevention should be based on local resistance patterns and individual risk, with consideration of rectal povidone-iodine preparation and targeted or otherwise appropriately selected antimicrobial prophylaxis. Management of suspected post-biopsy sepsis requires prompt recognition, microbiological sampling, early empiric antimicrobial therapy, assessment and treatment of organ dysfunction, appropriate fluid and vasopressor therapy when indicated, source control when necessary, and subsequent antimicrobial de-escalation according to microbiological results.
References
Wei, J. T., Barocas, D., Carlsson, S., et al. (2023). Early detection of prostate cancer: AUA/SUO guideline part II: Considerations for a prostate biopsy. J Urol, 210(1), 54–63. https://doi.org/10.1097/JU.0000000000003492
Bennett, H. Y., Roberts, M. J., Doi, S. A. R., & Gardiner, R. A. (2016). The global burden of major infectious complications following prostate biopsy. Epidemiol Infect, 144(8), 1784–1791. https://doi.org/10.1017/S0950268815002885
Gross, M. D., Alshak, M. N., Shoag, J. E., et al. (2019). Healthcare costs of post-prostate biopsy sepsis. Urology, 133, 11–15. https://doi.org/10.1016/j.urology.2019.06.011
Loeb, S., Vellekoop, A., Ahmed, H. U., et al. (2012). Infectious complications and hospital admissions after prostate biopsy in a European randomized trial. Eur Urol, 61(6), 1110–1114. https://doi.org/10.1016/j.eururo.2011.12.058
Wu, Y. P., Li, X. D., Ke, Z. B., et al. (2018). Risk factors for infectious complications following transrectal ultrasound-guided prostate biopsy. Infect Drug Resist, 11, 1491–1497. https://doi.org/10.2147/IDR.S171162
Balasubramanian, A., Wald, G., Rhodes, S., et al. (2025). Incidence and prevention strategies for postprostate biopsy infections in the United States from 2012 to 2021. Urol Oncol, 43(9), 527.e1–527.e8. https://doi.org/10.1016/j.urolonc.2025.05.005
Bonnedahl, J., Lundström, K. J., Lampa, E., et al. (2026). Risk of infectious complications after transperineal prostate biopsy compared to transrectal biopsy: Nationwide population-based cohort study in Sweden. Scand J Urol, 61, 44–50. https://doi.org/10.2340/sju.v61.45537
Shoag, J. E., Gaffney, C., Pantuck, M., et al. (2020). Risk factors for infection after prostate biopsy in the United States. Urology, 138, 113–118. https://doi.org/10.1016/j.urology.2019.12.023
Liss, M. A., Taylor, S. A., Batura, D., et al. (2014). Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy. J Urol, 192(6), 1673–1678. https://doi.org/10.1016/j.juro.2014.06.005
Roberts, M. J., Bennett, H. Y., Harris, P. N., et al. (2017). Prostate biopsy-related infection: A systematic review of risk factors, prevention strategies, and management approaches. Urology, 104, 11–21. https://doi.org/10.1016/j.urology.2016.12.011
Hadway, P., Barrett, L. K., Waghorn, D. J., et al. (2009). Urosepsis and bacteraemia caused by antibiotic-resistant organisms after transrectal ultrasonography-guided prostate biopsy. BJU Int, 104(11), 1556–1558. https://doi.org/10.1111/j.1464-410X.2009.08959.x
Sadahira, T., Sekito, T., Maruyama, Y., et al. (2025). Significance of targeted antimicrobial prophylaxis using rectal-culture selective screening media prior to transrectal prostate biopsy: A multicenter, randomized controlled trial. Urology, 196, 32–39. https://doi.org/10.1016/j.urology.2024.12.018
Togo, Y., & Yamamoto, S. (2017). Prevention of infectious complications after prostate biopsy procedure. Int J Urol, 24(7), 486–492. https://doi.org/10.1111/iju.13369
Pilatz, A., Dimitropoulos, K., Veeratterapillay, R., et al. (2020). Antibiotic prophylaxis for the prevention of infectious complications following prostate biopsy: A systematic review and meta-analysis. J Urol, 204(2), 224–230. https://doi.org/10.1097/JU.0000000000000814
Singh, P., Kumar, A., Yadav, S., et al. (2017). 'Targeted' prophylaxis: Impact of rectal swab culture-directed prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy. Investig Clin Urol, 58(5), 365–370. https://doi.org/10.4111/icu.2017.58.5.365
Pradere, B., Veeratterapillay, R., Dimitropoulos, K., et al. (2021). Nonantibiotic strategies for the prevention of infectious complications following prostate biopsy: A systematic review and meta-analysis. J Urol, 205(3), 653–663. https://doi.org/10.1097/JU.0000000000001399
Adibi, M., Hornberger, B., Bhat, D., et al. (2013). Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis. J Urol, 189(2), 535–540. https://doi.org/10.1016/j.juro.2012.08.194
Van Besien, J., Uvin, P., Weyne, E., et al. (2019). Use of fosfomycin as targeted antibiotic prophylaxis before prostate biopsy: A prospective randomized study. Int J Urol, 26(3), 391–397. https://doi.org/10.1111/iju.13883
D'Elia, C., Mian, C., Hanspeter, E., et al. (2019). Efficacy and safety of two fosfomycin regimens as antimicrobial prophylaxis for transrectal prostate biopsy: A randomised study. Urol Int, 103(4), 433–438. https://doi.org/10.1159/000502851
Örtegren, J., Kohestani, K., Elvstam, O., et al. (2024). Risk factors for infection after transrectal prostate biopsy: A population-based register study. Eur Urol Open Sci, 67, 1–6. https://doi.org/10.1016/j.euros.2024.06.015
Hiffa, A., Chen, M., Boghani, F., et al. (2024). Prostate biopsy sepsis prevention: External validation of an alcohol needle washing protocol. World J Urol, 42(1), 279. https://doi.org/10.1007/s00345-024-04955-w
Patel, U., Dasgupta, P., Amoroso, P., et al. (2012). Infection after transrectal ultrasonography-guided prostate biopsy: Increased relative risks after recent international travel or antibiotic use. BJU Int, 109(12), 1781–1785. https://doi.org/10.1111/j.1464-410X.2011.10561.x
Derin, O., Fonseca, L., Sanchez-Salas, R., & Roberts, M. J. (2020). Infectious complications of prostate biopsy: Winning battles but not war. World J Urol, 38(11), 2743–2753. https://doi.org/10.1007/s00345-020-03112-3
Evans, L., Rhodes, A., Alhazzani, W., et al. (2021). Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock 2021. Intensive Care Med, 47(11), 1181–1247. https://doi.org/10.1007/s00134-021-06506-y
Jacewicz, M., Günzel, K., Rud, E., et al. (2022). Antibiotic prophylaxis versus no antibiotic prophylaxis in transperineal prostate biopsies (NORAPP): A randomised, open-label, non-inferiority trial. Lancet Infect Dis, 22(10), 1465–1471. https://doi.org/10.1016/S1473-3099(22)00373-5
Stangl, F. P., Day, E., Vallée, M., et al. (2026). Infectious complications after transrectal versus transperineal prostate biopsy: A systematic review and meta-analysis. Eur Urol Focus, 12(2), 275–283. https://doi.org/10.1016/j.euf.2025.07.005
Hu, J. C., Assel, M., Allaf, M. E., et al. (2024). Transperineal versus transrectal magnetic resonance imaging-targeted and systematic prostate biopsy to prevent infectious complications: The PREVENT randomized trial. Eur Urol, 86(1), 61–68. https://doi.org/10.1016/j.eururo.2023.12.015
Stefanova, V., Buckley, R., Flax, S., et al. (2019). Transperineal prostate biopsies using local anesthesia: Experience with 1,287 patients. Prostate cancer detection rate, complications and patient tolerability. J Urol, 201(6), 1121–1126. https://doi.org/10.1097/JU.0000000000000156
Tsuboi, I., Matsukawa, A., Kardoust Parizi, M., et al. (2024). Infection risk reduction with povidone-iodine rectal disinfection prior to transrectal prostate biopsy: An updated systematic review and meta-analysis. World J Urol, 42(1), 252. https://doi.org/10.1007/s00345-024-04941-2
Madhavan, K., Bhargava, P., Phonde, A., et al. (2025). Preventing infectious complications following prostate biopsy: A systematic review and network meta-analysis of randomized controlled trials of alternative approaches to transrectal biopsy with empirical antibiotic prophylaxis therapy. Eur Urol Focus, 11(2), 301–311. https://doi.org/10.1016/j.euf.2024.09.011
Pilatz, A., Veeratterapillay, R., Dimitropoulos, K., et al. (2021). European Association of Urology position paper on the prevention of infectious complications following prostate biopsy. Eur Urol, 79(1), 11–15. https://doi.org/10.1016/j.eururo.2020.10.019
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Szymon Antoni Kaźmierczak, Natalia Sobieska
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
